PCVX logo

Vaxcyte, Inc. (PCVX) CAPEX

Annual CAPEX:

$119.16M+$51.28M(+75.55%)
December 31, 2024

Summary

  • As of today, PCVX annual capital expenditures is $119.16 million, with the most recent change of +$51.28 million (+75.55%) on December 31, 2024.
  • During the last 3 years, PCVX annual CAPEX has risen by +$112.60 million (+1717.83%).
  • PCVX annual CAPEX is now at all-time high.

Performance

PCVX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Quarterly CAPEX:

$9.76M-$17.00M(-63.53%)
June 30, 2025

Summary

  • As of today, PCVX quarterly capital expenditures is $9.76 million, with the most recent change of -$17.00 million (-63.53%) on June 30, 2025.
  • Over the past year, PCVX quarterly CAPEX has dropped by -$35.62 million (-78.50%).
  • PCVX quarterly CAPEX is now -82.91% below its all-time high of $57.07 million, reached on December 31, 2023.

Performance

PCVX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM CAPEX:

$104.61M-$35.62M(-25.40%)
June 30, 2025

Summary

  • As of today, PCVX TTM capital expenditures is $104.61 million, with the most recent change of -$35.62 million (-25.40%) on June 30, 2025.
  • Over the past year, PCVX TTM CAPEX has dropped by -$10.85 million (-9.39%).
  • PCVX TTM CAPEX is now -28.45% below its all-time high of $146.20 million, reached on September 30, 2024.

Performance

PCVX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

PCVX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+75.5%-78.5%-9.4%
3Y3 Years+1717.8%+940.0%+1403.3%
5Y5 Years+9871.5%+10000.0%+7447.8%

PCVX CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+1937.6%-82.9%+1057.2%-28.4%+1688.9%
5Y5-Yearat high>+9999.0%-82.9%>+9999.0%-28.4%+8957.4%
All-TimeAll-Timeat high>+9999.0%-82.9%>+9999.0%-28.4%>+9999.0%

PCVX CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$9.76M(-63.5%)
$104.61M(-25.4%)
Mar 2025
-
$26.75M(-10.9%)
$140.23M(+17.7%)
Dec 2024
$119.16M(+75.6%)
$30.03M(-21.1%)
$119.16M(-18.5%)
Sep 2024
-
$38.08M(-16.1%)
$146.20M(+26.6%)
Jun 2024
-
$45.37M(+699.1%)
$115.46M(+59.9%)
Mar 2024
-
$5.68M(-90.1%)
$72.23M(+0.1%)
Dec 2023
$67.88M(+1060.7%)
$57.07M(+677.6%)
$72.16M(+344.5%)
Sep 2023
-
$7.34M(+242.9%)
$16.23M(+66.7%)
Jun 2023
-
$2.14M(-61.8%)
$9.74M(+14.1%)
Mar 2023
-
$5.61M(+389.0%)
$8.54M(+46.0%)
Dec 2022
$5.85M
$1.15M(+36.1%)
$5.85M(-3.9%)
Sep 2022
-
$843.00K(-10.1%)
$6.08M(-12.6%)
Jun 2022
-
$938.00K(-67.9%)
$6.96M(-15.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
$2.92M(+111.3%)
$8.23M(+25.5%)
Dec 2021
$6.55M(+467.5%)
$1.38M(-19.6%)
$6.55M(+11.2%)
Sep 2021
-
$1.72M(-22.1%)
$5.89M(+40.2%)
Jun 2021
-
$2.21M(+77.2%)
$4.21M(+104.9%)
Mar 2021
-
$1.25M(+72.6%)
$2.05M(+77.7%)
Dec 2020
$1.16M(-3.3%)
$722.00K(+2389.7%)
$1.16M(-16.7%)
Sep 2020
-
$29.00K(-47.3%)
$1.39M(-2.2%)
Jun 2020
-
$55.00K(-84.2%)
$1.42M(-7.3%)
Mar 2020
-
$349.00K(-63.4%)
$1.53M(+27.9%)
Dec 2019
$1.20M(-32.6%)
$953.00K(+1488.3%)
$1.20M(+393.8%)
Sep 2019
-
$60.00K(-63.9%)
$242.00K(+33.0%)
Jun 2019
-
$166.00K(+937.5%)
$182.00K(+1037.5%)
Mar 2019
-
$16.00K
$16.00K
Dec 2018
$1.77M
-
-

FAQ

  • What is Vaxcyte, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual CAPEX year-on-year change?
  • What is Vaxcyte, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly CAPEX year-on-year change?
  • What is Vaxcyte, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM CAPEX year-on-year change?

What is Vaxcyte, Inc. annual capital expenditures?

The current annual CAPEX of PCVX is $119.16M

What is the all-time high annual CAPEX for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual capital expenditures is $119.16M

What is Vaxcyte, Inc. annual CAPEX year-on-year change?

Over the past year, PCVX annual capital expenditures has changed by +$51.28M (+75.55%)

What is Vaxcyte, Inc. quarterly capital expenditures?

The current quarterly CAPEX of PCVX is $9.76M

What is the all-time high quarterly CAPEX for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly capital expenditures is $57.07M

What is Vaxcyte, Inc. quarterly CAPEX year-on-year change?

Over the past year, PCVX quarterly capital expenditures has changed by -$35.62M (-78.50%)

What is Vaxcyte, Inc. TTM capital expenditures?

The current TTM CAPEX of PCVX is $104.61M

What is the all-time high TTM CAPEX for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM capital expenditures is $146.20M

What is Vaxcyte, Inc. TTM CAPEX year-on-year change?

Over the past year, PCVX TTM capital expenditures has changed by -$10.85M (-9.39%)
On this page